NCT03724110 (TELECAST-TIA) is a clinical trial of Telestroke in Transient Ischemic Attack, sponsored by University of Minnesota.

Who is sponsoring NCT03724110?

NCT03724110 is sponsored by University of Minnesota.

What drugs are being tested in NCT03724110?

Interventions in NCT03724110: Telestroke.

What condition does NCT03724110 study?

NCT03724110 studies Transient Ischemic Attack.

Is NCT03724110 still recruiting?

NCT03724110 is currently completed. Last updated 18 October 2023.

Last reviewed 2023-10-18 · How we verify

NCT03724110: TELECAST-TIA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Telestroke for Comprehensive Transient Ischemic Attack Care in Acute Stroke Ready Hospitals

Completed Last updated 18 October 2023

What this trial tests

trial testing Telestroke in Transient Ischemic Attack in 300 participants. Completed in 2 July 2022.

Timeline

2 October 2018

Primary endpoint
2 July 2019

2 July 2022

Quick facts

Lead sponsor	University of Minnesota
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	2 October 2018
Primary completion	2 July 2019
Estimated completion	2 July 2022
Sites	5 locations across United States

Drugs / interventions tested

Telestroke

Conditions studied

Transient Ischemic Attack — all drugs for Transient Ischemic Attack →

Sponsor

University of Minnesota

Who can join

18 and older, any sex, with Transient Ischemic Attack. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

TELECAST-TIA is a prospective single-center study evaluating guideline-based transient ischemic attack (TIA) treatment at an Acute Stroke Ready Hospital (ASRH) pre- and post-initiation of a specialist telestroke inpatient rounding service. TELECAST-TIA will study the following clinical endpoints: diagnostic stroke evaluation, secondary stroke prevention, health screening and evaluation, stroke education, inpatient complications, and stroke recurrence rates. Additional relevant non-clinical data will include patient and provider satisfaction scores, transfer patterns, and a cost analysis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Neuroprotection in Acute Ischemic Stroke: A Battle Against the Biology of Nature.
Ghozy S, Reda A, Varney J, Elhawary AS, et al · · 2022 · cited 51× · PMID 35711268 · DOI 10.3389/fneur.2022.870141

Verify or expand the search:

Other trials of Telestroke

Trials testing the same drug.

NCT04761874 — Telestroke at Comprehensive Stroke Center During the COVID-19 Pandemic · NA · completed
NCT03672890 — Telestroke for Comprehensive Stroke Care in Acute Stroke Ready Hospitals · completed

Other recruiting trials for Transient Ischemic Attack

Currently open trials in the same condition.

NCT07242768 — Follow-up Extension Study of Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · recruiting
NCT06615726 — Regular Physical Exercise in Patients With Symptomatic Intracranial Arterial Stenosis · Phase 3 · active not recruiting
NCT06515392 — TIA Scores' Mortality Predictions and Recurrent TIA and Stroke Prediction · recruiting
NCT06653348 — Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke · Phase 2, PHASE3 · recruiting
NCT06091319 — Florbetaben for Imaging of Vascular Amyloid · recruiting

Other University of Minnesota trials

Trials by the same sponsor.

NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03724110 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
Last refreshed: 18 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03724110.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing